Weed Bill Passes State and Assembly Committees in N.J., But Success Isn't Guaranteed
*By Christian Smith*
Committees in the New Jersey state Senate and Assembly may have both approved a bill that would legalize recreational marijuana in the state, but the bill's success isn't certain, said Politico New Jersey Reporter Sam Sutton.
"It's still very contentious," Sutton said Wednesday in an interview on Cheddar. "There are a number of Democrats, most notably, former Governor Richard Cody, who is in the Senate now, and Ron Rice, who is a Senator from Essex County, who are both Democrats who are very, very, very opposed to any effort to legalize marijuana for recreational purposes."
The bill, which must now be approved by the full New Jersey legislature, would legalize possession of small amounts of marijuana for adults over the age of 21, and would establish a more robust statewide cannabis industry (the state currently allows the sale of medical marijuana).
While most Democrats support legalizing recreational marijuana, debate persists on how the product should be taxed. As the bill is currently written, marijuana products would be taxed 12 percent with an additional 2 percent excise tax for local governments.
Democratic Gov. Phil Murphy's office wants marijuana taxed at 25 percent.
Barring any major developments, Sutton said that people in the Garden State could be able to buy recreational pot in as few as six to eight months ー but that's the best-case scenario for pot enthusiasts.
"More realistically, I would say a year to 18 months from now," Sutton said.
Exclusive: Behr’s Andy Lopez reveals how ChatHUE, a bold collaboration with Google, is using AI to transform how we explore, choose, and connect with color.
Brian Vendig, President & CIO of MJP Wealth Advisors, joins to break down Q2 bank earnings and what they signal for markets, investors, and the economy ahead.
Are Gen Z and Millennials done with alcohol? Bacardi's Tony Latham breaks down trends, new preferences, and insights from the 2025 Cocktail Trends Report.
Comscore’s Paul Dergarabedian breaks down the battle of summer blockbusters, from Superman to Jurassic World and Fantastic Four and what it means for studios.
VENU CEO JW Roth breaks ground on a 20,000-seat, state-of-the-art amphitheater in Texas—part of a $300M public-private expansion to redefine live music.
Despite healthcare spending cuts, medtech stocks like Edwards Life Sciences, Stryker, and Boston Scientific are rising, especially those serving older pati
Joby CPO Eric Allison discusses the UAE’s historic EVTOL take off, marking Dubai as the launchpad for global air taxi adoption and Joby’s commercial readiness.
CFRA’s Angelo Zino joins us to unpack Meta’s Superintelligence Labs and what it means for the future of AI, innovation, and the company’s bold new direction.